1 / 38

Chapter 52 Drug Therapy for Seizure Disorders and Spasticity

Chapter 52 Drug Therapy for Seizure Disorders and Spasticity. Seizure Disorders. Seizure: brief episode of abnormal electrical activity in the brain’s nerve cells May occur as single events May occur in a chronic, recurrent pattern Disorder known as epilepsy

Download Presentation

Chapter 52 Drug Therapy for Seizure Disorders and Spasticity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapter 52 Drug Therapy for Seizure Disorders and Spasticity

  2. Seizure Disorders • Seizure: brief episode of abnormal electrical activity in the brain’s nerve cells • May occur as single events • May occur in a chronic, recurrent pattern • Disorder known as epilepsy • Convulsion: tonic–clonic type of seizure characterized by spasmodic contractions of involuntary muscles

  3. Question • Is the following statement True or False? • Seizure and convulsion are different terms for the same disorder.

  4. Answer • False • Rationale: A seizure is a brief episode of abnormal electrical activity in the brain’s nerve cells. A convulsion is a tonic–clonic type of seizure characterized by spasmodic contractions of involuntary muscles.

  5. Epilepsy • Usually requires long-term therapy • Characterized by sudden, abnormal, hypersynchronous firing of neurons • Diagnosed by • Clinical signs and symptoms of seizure activity • Presence of abnormal brain wave patterns on EEG

  6. Epilepsy (cont.) • Classifications • Idiopathic • Attributable to secondary cause • Developmental defects • Metabolic disease, birth injury • Fever, acquired neurologic disorder • Alcohol or other drug effects

  7. Question • Is the following statement True or False? • Epilepsy can be classified as either idiopathic or attributable to secondary causes.

  8. Answer • True • Rationale: Epilepsy can be classified as either idiopathic or attributable to secondary causes.

  9. Seizure Classifications • Partial seizures • Begin in a specific area of the brain • Often indicate a localized brain lesion • Birth injury • Trauma • Stroke • Tumor

  10. Seizure Classifications (cont.) • Partial seizures (cont.) • Symptoms range from • Simple motor and sensory effects • To • More complex abnormal movements and bizarre behavior

  11. Seizure Classifications (cont.) • Partial seizures (cont.) • Movements are usually • Automatic • Repetitive • Inappropriate to the situation • Chewing, swallowing • Aversive movements

  12. Seizure Classifications (cont.) • Partial seizures (cont.) • Simple partial seizures • Consciousness not impaired • Complex partial seizures • Level of consciousness is decreased.

  13. Question • Is the following statement True or False? • Partial seizures have no discernible origin in the brain.

  14. Answer • False • Rationale: Generalized seizures have no discernible origin in the brain. Partial seizures begin in a specific area of the brain.

  15. Seizure Classifications (cont.) • Generalized seizures • Bilateral • Symmetric • No discernible point of origin in the brain • Most common type • Tonic–clonic

  16. Seizure Classifications (cont.) • Generalized seizures (cont.) • Absence seizure • Alteration in consciousness that lasts only a few seconds • Myoclonic • Contraction of muscle or group of muscles • Akinetic • Absence of movement

  17. Seizure Classifications (cont.) • Status epilepticus • Life-threatening emergency • Characteristics include • Generalized tonic–clonic convulsions lasting for several minutes • Generalized tonic–clonic convulsions occurring at close intervals during which consciousness is not regained

  18. Seizure Classifications (cont.) • Status epilepticus (cont.) • Characteristics include (cont.) • Hypotension, hypoxia, and cardiac dysrhythmias • High risk of permanent brain damage and death • Unless prompt, appropriate treatment is instituted

  19. Seizure Classifications (cont.) • Status epilepticus (cont.) • Causes • Abruptly stopping AEDs in diagnosed seizure disorders • Brain trauma or tumors • Systemic or CNS infections • Alcohol withdrawal, drug overdose

  20. Generalized Characteristics of Antiseizure Drugs • Usually control seizure activity • Do not cure underlying disorder • Difficulties • Trials of different drugs • Monotherapy versus combination therapy • Titrating dosage

  21. Generalized Characteristics of Antiseizure Drugs (cont.) • Difficulties (cont.) • Lack of seizure control during drug selection and titration • Social stigma • Adverse medication effects • Often leading to poor compliance • Undesirable drug interactions

  22. Phenobarbital • Depresses the CNS by inhibiting the conduction of impulses in the ascending reticular activating system, thus depressing the cerebral cortex and cerebellar function • Used as a sedative and antiepileptic agent in the treatment of generalized tonic–clonic and partial seizures • Parenteral form is used to control acute seizures.

  23. Adverse Effects • CNS depression • Cognitive impairment with sedation • Somnolence, agitation, confusion, vertigo, and nightmares • Stevens-Johnson syndrome • Black box warning

  24. Benzodiazepines • Used as antidepressants, antiepileptics, or skeletal muscle relaxants • Used for treatment of severe recurrent convulsive seizures and status epilepticus • Contraindications include acute narrow-angle glaucoma, shock, coma, acute alcohol intoxication, and pregnancy

  25. Neurontin • Used in treatment of partial seizures • It has the ability to inhibit postsynaptic responses and block post-tetanic potentiation. • Patient teaching

  26. Dilantin • Oldest and most widely used antiepileptic • Stabilizes the neuronal membrane by delaying the influx of sodium ions into the neurons and preventing the excitability caused by excessive stimulation • Used to control tonic–clonic seizures, psychomotor seizures, and nonepileptic seizures

  27. Adverse Effects • Ataxia, drowsiness, lethargy • Nausea and vomiting • Gingival hyperplasia • Increased risk of osteoporosis • Patient teaching

  28. Monitoring Antiepileptic Drug Therapy • Periodic measurement of serum drug levels • Document blood levels and connections with • Drug dosages, seizure control, or adverse drug effects • Assess • Therapeutic failures

  29. Monitoring Antiepileptic Drug Therapy (cont.) • Assess (cont.) • Drug malabsorption • Patient noncompliance • Guide dosage adjustments. • Evaluate possible drug-related adverse effects.

  30. Drug Therapy Failure • Causes • Noncompliance, inadequate drug dosage • Incorrect diagnosis or medication for seizure type • Too frequent changes or premature withdrawal • Drug overdoses, use of alcohol or recreational drugs • Severe electrolyte imbalance

  31. Use in Special Populations • Children • Older adults • Patients with renal impairment • Patients with hepatic impairment • Patients with critical illness • Home care

  32. Definitions • Skeletal muscle relaxants are used to decrease muscle spasms or spasticity that occurs within neurologic and musculoskeletal disorders. • Muscle spasm: sudden, involuntary, painful muscle contraction • May be clonic or tonic • Spasticity: increased muscle tone or contraction and stiff, awkward movements

  33. Question • Is the following statement True or False? • Spasticity is a sudden, involuntary, painful muscle contraction.

  34. Answer • False • Rationale: Spasticity is increased muscle tone or contraction and stiff, awkward movements. Muscle spasm is a sudden, involuntary, painful muscle contraction.

  35. General Characteristics of Skeletal Muscle Relaxants • Mechanism of action • General depression of the CNS • Indications for use • Primarily as adjuncts to other treatments • Physical therapy • Spastic disorders

  36. General Characteristics of Skeletal Muscle Relaxants (cont.) • Contraindications for use • Impaired renal or hepatic function • Respiratory depression • Patients who must be alert for activities of daily living

  37. Principles of Skeletal Muscle Relaxant Therapy • Goal: relieve pain, muscle spasm, and muscle spasticity without impairing the ability to perform self-care activities • Drug selection • Medication used depends mainly on the disorder being treated.

  38. Principles of Skeletal Muscle Relaxant Therapy (cont.) • Use in special populations • Children • Older adults • Impaired renal or hepatic function • Home care

More Related